Vimarsana
Biggest News Aggregation in the World

Page 11 - Cell Pouch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Pouch Today - Breaking & Trending Today

Sernova : NEW Sernova Investor Presentation - January 2023 - Vimarsana News

Sernova : NEW Sernova Investor Presentation - January 2023

Advancing cell therapeutics to develop 'functional cures' J a n u a r y 2 0 2 3 ... | December 23, 2022

Sernova to Participate in the Roth Inaugural Healthcare - Vimarsana News

Sernova to Participate in the Roth Inaugural Healthcare

LONDON, Ontario, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in...

New Data, Film Highlight Islet Cell Transplantation Progress - Vimarsana News

New Data, Film Highlight Islet Cell Transplantation Progress

A new documentary, to be released June 24, shows the human side of islet cell transplantation research for type 1 diabetes and follows encouraging data presentations at two medical meetings.

Sernova Corp. Expected to Post FY2024 Earnings of ($0.02) Per Share (CVE:SVA) - Vimarsana News

Sernova Corp. Expected to Post FY2024 Earnings of ($0.02) Per Share (CVE:SVA)

Sernova Corp. (CVE:SVA – Get Rating) – Equities researchers at Leede Jones Gab issued their FY2024 earnings estimates for shares of Sernova in a note issued to investors on Tuesday, May 17th. Leede Jones Gab analyst D. Loe anticipates that the company will post earnings per share of ($0.02) for the year. Leede Jones Gab […]

Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a 'Functional Cure' for Diabetes | DNA RNA and Cells - Vimarsana News

Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a 'Functional Cure' for Diabetes | DNA RNA and Cells

Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes